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Introduction
Catecholaminergic polymorphic ventricular tachycardia 
(CPVT) is characterized by episodic syncope resulting from fast 
VT (bidirectional or polymorphic) occurring during exercise/acute 
emotion in individuals without structural cardiac abnormalities. 
Mean age of onset is between seven and nine years, although 
onset as late as the fourth decade of life has been reported. We 
present the oldest reported patient with index event of CPVT.
Our patient’s atypical condition, already emphasized by a 
very late CPVT event, included multiple consecutive episodes 
of device-related infection.
Case Report
A 45-year-old male patient, the offspring of consanguineous 
(first-cousin) parents and with mild hepatic dysfunction 
(alcoholic etiology), was admitted for syncope associated 
to acute anxiety. Family history of sudden death (SD) was 
reported: four brothers had died suddenly at ages 10-20 
(autopsies inconclusive, but deaths reportedly attributed 
to epilepsy). He denied ever having had palpitations, 
dyspnea, syncope or chest pain. Physical examination was 
unremarkable, except for mild bruising/ecchymosis in both 
feet, and baseline electrocardiogram showed sinus tachycardia, 
only (due to anxiety). At the emergency department, an 
episode of sustained polymorphic VT [pVT] (with intermittent 
beat-to-beat axis variation) caused presyncope (Figure 1). 
Echocardiogram, cardiac-MRI and coronary angiography 
results were normal, but exercise stress testing disclosed 
runs of non-sustained ventricular arrhythmia starting at the 
second stage of Bruce protocol (isolate premature ventricular 
complexes, progressively followed by bigeminy, couplets and 
runs of non-sustained VT) (Figure 2). Programmed electrical 
stimulation failed to induce ventricular arrhythmias, but 
isoprenaline at increasing infusion rates led to spontaneous 
short bursts of non-sustained pVT.
Syncope caused by bidirectional or pVT induced by acute 
anxiety despite absence of structural heart disease or baseline 
electrocardiographic abnormalities suggested CPVT, especially 
considering family history of SD and early induction of 
malignant ventricular arrhythmias during exercise stress testing. 
Nevertheless, genetic testing was negative for ryanodine 
receptor channel (RYR2) and calsequestrin (CASQ2) gene 
mutations. A beta-blocker was prescribed (plus Diazepam 
SOS) and a defibrillator (ICD) was implanted (ICD lead inserted 
through left subclavian vein). Following the procedure, the 
patient developed a hematoma that resolved conservatively. 
Three weeks later, the patient received appropriate defibrillator 
shock for fast VT, with no further recurrence.
Exercise stress tests were performed on the remaining 
patient’s brothers. Following early induction of sustained VT 
in one brother with history of syncope, an ICD was implanted.
The following paragraphs summarize subsequent 
hospitalizations:
• Month 4: Pocket infection causing generator extrusion, 
exudate positive for multiresistant Staphylococcus 
epidermidis. Three-week course of vancomycin 
prematurely interrupted (18th day) due to severe 
thrombocytopenia/leukopenia and generalized 
exanthema/pruritus. Device extraction, but one week 
later, unexpected hemodynamic shock (septic/allergic?) 
was aggressively treated with fluid resuscitation, 
dopamine, prednisolone, linezolid (four-week 
treatment). Transesophageal echocardiogram performed 
two weeks later revealed no signs of IE.
•	 Month 6: End of four-week linezolid treatment 
and new generalized petechial rash, pruriginous 
desquamative dermatitis, fever, kidney failure, severe 
thrombocytopenia. ICD pocket abscess documented 
and surgically drained. Patient started on meropenem. 
Exudate cultures subsequently positive for vancomycin-
resistant Staphylococcus aureus and allergic reaction to 
meropenem (generalized exanthema/pruritus), then 
replaced by linezolid (four-week treatment). Three 
weeks after starting linezolid, as patient remained 
apyretic and had very low inflammatory markers, ICD 
re-implantation on contralateral side and patient was 
discharged soon thereafter on antibiotic therapy. One 
week later, a new pocket hematoma occurred. 
•	 Month 7: Twelve days following previous discharge, patient 
was re-admitted for sepsis and urticarial exanthema. 
Possibility of allergy to amoxicillin (initiated three days 
before for respiratory infection), but echocardiogram 
disclosed a two-square centimeter mass adherent to 
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Figure 1 – Polymorphic ventricular tachycardia with intermittent periods of alternating bidirectional QRS axis.
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defibrillator lead. Patient was restarted on linezolid 
(five-week treatment). Intracardiac mass was eliminated.
•	 Month 9: Patient re-admitted for new pocket infection. 
ICD was extracted and new antibiotic course initiated. 
Considering high risk of reinfection and patient 
preference, defibrillator was not re-implanted.
Six months later, patient is asymptomatic. Patient’s brother 
had several runs of non-sustained VT during follow-up, but 
no pocket hematoma/infection was reported.
Discussion
CPVT is a potentially lethal inherited arrhythmogenic 
disorder, characterized by adrenergically-mediated 
ventricular arrhythmias, typically bidirectional or pVT, 
manifested especially in children/teenagers1. We present the 
case of a 45-year-old patient diagnosed with CPVT following 
its first manifestation. 
To our knowledge, this is the oldest reported patient first 
presenting with this condition, which raised diagnostic doubts, 
especially considering genetic testing was negative for RYR2/
CASQ2 mutations. However, the clinical picture was highly 
suggestive of CPVT:
•	 Syncope caused by pVT during acute emotion;
•	 Alternating 180° QRS axis on beat-to-beat basis 
(bidirectional VT), although irregular pVT without stable 
QRS vector alternans was also documented;
•	 Ventricular arrhythmias of progressive complexity during 
exercise stress testing and isoprenaline infusion;
•	 Absence of electrocardiographic and structural cardiac 
abnormalities, electrolyte imbalance or drug treatment 
potentially associated to pVT.
Furthermore, mutations in the RYR2 and CASQ2 genes 
account for 51-56% of CPVT cases only, showing significant 
locus heterogeneity. The presence of other as-yet unidentified/
unmapped loci has been postulated2.
CPVT should be considered in the differential diagnosis 
of adrenergically-mediated syncope in otherwise healthy 
individuals. Presence/absence of right ventricular structural 
abnormalities must be evaluated to exclude presence of a rare 
variant of arrhythmogenic right ventricular cardiomyopathy 
(ARVC) allelic to RYR2-related CPVT3. Our patient’s right 
ventricle showed normal structure/contractility in cardiac 
MRI and programmed electrical stimulation could not 
induce ventricular arrhythmias, contrary to isoprenaline 
infusion, favoring catecholamine sensitive automaticity as the 
mechanism for this VT (contrary to the reentry mechanism of 
ARVC). Short-coupled VT resembles CPVT; however, it lacks 
an association between arrhythmic episodes and adrenergic 
stimuli and typical bidirectional pattern of CPVT4. 
Exercise-related syncope is also found in LQT1 variant of 
long-QT syndrome. These patients may have normal QT 
intervals and therefore resemble CPVT, but they do not usually 
show ventricular arrhythmias of progressive complexity during 
graded exercise5. There were no ST-T changes or QT interval 
prolongation preceding pVT runs, as expected in Brugada and 
long QT syndromes, respectively.
Rare CPVT cases have been reported in middle-aged adult 
patients. Severe CPVT forms usually die during childhood 
and people tend to become more sedentary after school 
graduation, hindering the diagnosis. Autosomal dominant 
cardiac conditions (possibly but not necessarily our case) 
show a wide range in severity and age of onset. Clinical 
presentation within a given kindred may vary widely between 
family members, which may be explained by genetic (earlier 
onset with multilocus mutations and double heterozygote) 
and environmental modifying factors6.
The lifetime risk of further episodes of IE among survivors 
ranges between 2-22%7. “Relapse” suggests an incompletely 
treated episode resulting in emergence of original microorganism 
from protected sources (prosthetic hardware/intracardiac 
devices), requiring a search for persistent focus of infection, 
longer course of treatment or surgical therapy. “Reinfection” 
concerns infection with a new microorganism. The need 
for accurate differentiation between relapse/reinfection, 
preferably using molecular strain-typing methodology, must 
be reinforced, considering its therapeutic impact.  Reinfection 
with persistent colonizing strain of S. aureus could give the 
erroneous impression of relapse and an episode of IE may 
be polyclonal although involving a single species, as reported 
for Staphylococcus epidermidis8. As polyclonality interferes 
with antibiotic susceptibility, this observation has important 
consequences for treatment of device-related coagulase-
negative Staphylococcus endocarditis (S. epidermidis) and 
suggests the need for exhaustive antibiotic susceptibility testing.
Our patient had both relapsed infection and reinfection. We 
followed ESC guidelines on IE (prolonged antibiotic treatment, 
device removal, reimplantation postponed to allow weeks 
of antibiotic treatment, reimplantation on contralateral side), 
but severe allergic reactions and intolerance to vancomycin/
meropenem were limiting. Potentially persistent/resistant foci 
of infection attached to the defibrillation lead and the infection 
polyclonal nature may have had a role as well. Possibility of 
immunodeficiency and hemorrhagic discrasy (mainly of secondary 
hemostasis) was considered, as our patient was the offspring of 
consanguineous first-cousin parents. Presence of hematoma, 
immunodeficiency and pocket instrumentation/revision increase 
risk of recurrent pocket infection or device-related IE9.
Epicardial defibrillation system implantation was considered. 
However, placing the coil in the pericardial space may lead to 
pericarditis, adhesions/fibrosis, infection and arrhythmogenesis 
and long-term stability/reliability are still unknown10. Left 
cardiac sympathetic denervation may be performed in case 
of syncope recurrence. Wearable cardioverter-defibrillator 
vests (such as LifeVest) are not yet available in our country.
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